Subsense
Covina
About Subsense
Subsense develops non-surgical brain-computer interface (BCI) technologies that link neural activity with external systems using engineered nanoparticles and integrated hardware and software. The company focuses on bidirectional interfaces designed to record and stimulate brain signals without surgical implants, targeting applications in neurological treatment, human-machine interaction and neural diagnostics. Its offerings include nanoparticle systems, signal processing platforms and research collaborations with academic institutions to advance non-invasive neural connectivity. Subsense also works on tools and algorithms to interpret brain activity for potential therapeutic and assistive uses in neurological conditions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $27.0M
- Funding stage: Seed
- Last round: Seed (Dec 2025)
- Website: subsense-bci.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical Device, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/subsense-52852 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.